Endoscopic Resection Versus Surgical Resection for T1/T2 Duodenal Adenocarcinoma: Considerations of Nodal Upstaging

View at publisher
Authors: Bryant S. Morocho, Abdul Saied Calvino, Ponnandai Sadasivan Somasundar, Steve Kwon
Cited by: 0
References: 46

Abstract

BACKGROUND AND OBJECTIVE: Endoscopic resection (ER) is increasingly used for early-stage duodenal adenocarcinoma (DA). This study aimed to identify factors guiding ER selection for clinical T1/T2N0 DA. METHODS: A retrospective National Cancer Database analysis (2010-2021) included patients with clinical T1/T2N0M0 DA with available pathological staging among those who underwent surgical resection. Outcomes were overall survival and lymph node upstaging (LNU). Survival was evaluated using Cox proportional hazard models, and predictors of LNU were assessed using logistic regression. RESULTS: Among 527 patients, 68 underwent ER and 459 underwent a major resection. Overall survival did not differ between the two groups (HR: 0.96, 95% CI: 0.65-1.40). Among major resections, nodal upstaging occurred in about 40% of patients and was associated with worse survival (T1 HR: 1.72, 95% CI: 1.18-2.50) and (T2 HR: 2.06, 95% CI: 1.28-3.33). Poor differentiation (OR: 2.83, 95% CI: 1.08-7.45), lymphovascular invasion (OR 7.19, 95% CI: 4.48-11.53), and age (≥ 80 compared to < 65-OR: 0.40, 95% CI: 0.20-0.82) were significant predictors of LNU. CONCLUSION: Nearly 40% of clinically node-negative T1/T2 DA patients who underwent a major resection had LNU, which was associated with worse overall survival. Pathologic features should guide ER selection.

Fields of Study & Subjects

Gastric Cancer Management and Outcomes Pancreatic and Hepatic Oncology Research Cholangiocarcinoma and Gallbladder Cancer Studies

Publication details

Journal / source
Journal of Surgical Oncology
Volume
133
Issue
5
Pages
632–641
Publication date
15 February 2026
Language
EN